These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12042783)

  • 21. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
    Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
    AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The AIDS paradox.
    Curtin ME
    Microbiol Sci; 1986 Dec; 3(12):364-5. PubMed ID: 2908680
    [No Abstract]   [Full Text] [Related]  

  • 23. Spontaneous regression of bowenoid papulosis in a patient with acquired immunodeficiency syndrome after an increase in peripheral CD4+ T lymphocytes.
    Kawakami A; Saga K; Ono I; Hida T; Jimbow K; Yamashita T
    Int J Dermatol; 2009 Feb; 48(2):210-2. PubMed ID: 19200210
    [No Abstract]   [Full Text] [Related]  

  • 24. [Linking Nef with the immunological and virological determinants of AIDS].
    Gómez-Icazbalceta G; Larralde C
    Rev Invest Clin; 2009; 61(3):243-51. PubMed ID: 19736813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The infection and immunity of HIV: hope and thought].
    Shang H
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
    [No Abstract]   [Full Text] [Related]  

  • 26. AIDS and the single cell.
    Curtin ME
    Microbiol Sci; 1986 Sep; 3(9):274-5. PubMed ID: 2908681
    [No Abstract]   [Full Text] [Related]  

  • 27. A multicenter evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand.
    Pattanapanyasat K; Shain H; Noulsri E; Lerdwana S; Thepthai C; Prasertsilpa V; Likanonsakul S; Yothipitak P; Nookhai S; Eksaengsri A
    Cytometry B Clin Cytom; 2005 May; 65(1):29-36. PubMed ID: 15800883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML.
    Berger JR
    AIDS; 2003 Jul; 17(10):1557-9. PubMed ID: 12824794
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of upstream U3 sequences in HIV-1 replication and CD4+ T cell depletion in human lymphoid tissue ex vivo.
    Münch J; Rajan D; Rücker E; Wildum S; Adam N; Kirchhoff F
    Virology; 2005 Oct; 341(2):313-20. PubMed ID: 16102792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ T-cell subsets: what really counts in preventing HIV disease?
    Mason RD; De Rose R; Kent SJ
    Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
    Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
    Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection versus immunity: What's the balance?
    Shearer WT
    J Allergy Clin Immunol; 2005 Aug; 116(2):263-6. PubMed ID: 16083777
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell cycle distribution of CD4+ lymphocytes in HIV-1-infected subjects.
    Chaves MM; Kallas EG
    Cytometry B Clin Cytom; 2004 Nov; 62(1):46-51. PubMed ID: 15476192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
    Betts MR; Gray CM; Cox JH; Ferrari G
    Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune activation and AIDS pathogenesis.
    Sodora DL; Silvestri G
    AIDS; 2008 Feb; 22(4):439-46. PubMed ID: 18301056
    [No Abstract]   [Full Text] [Related]  

  • 36. A genetically engineered live-attenuated simian-human immunodeficiency virus that co-expresses the RANTES gene improves the magnitude of cellular immunity in rhesus macaques.
    Shimizu Y; Inaba K; Kaneyasu K; Ibuki K; Himeno A; Okoba M; Goto Y; Hayami M; Miura T; Haga T
    Virology; 2007 Apr; 361(1):68-79. PubMed ID: 17157892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein.
    Lawson VA; Silburn KA; Gorry PR; Paukovic G; Purcell DF; Greenway AL; McPhee DA
    Virology; 2004 Sep; 327(1):70-82. PubMed ID: 15327899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simpler tests for immune cells could transform AIDS care in Africa.
    Willyard C
    Nat Med; 2007 Oct; 13(10):1131. PubMed ID: 17917650
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
    Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
    AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [AIDS. Excessive decrease in T4 lymphocytes].
    Fortschr Med; 1988 Nov; 106(33):15. PubMed ID: 2905322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.